Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to $3.8 million.

  • Stemtech's Liabilities and Shareholders Equity rose 320.73% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year increase of 369.1%. This contributed to the annual value of $3.8 million for FY2024, which is 268.71% up from last year.
  • According to the latest figures from Q3 2025, Stemtech's Liabilities and Shareholders Equity is $3.8 million, which was up 320.73% from $3.9 million recorded in Q2 2025.
  • Stemtech's 5-year Liabilities and Shareholders Equity high stood at $6.3 million for Q3 2021, and its period low was $3.6 million during Q1 2024.
  • In the last 5 years, Stemtech's Liabilities and Shareholders Equity had a median value of $4.1 million in 2023 and averaged $4.3 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 1418.5% in 2021, then plummeted by 3068.21% in 2022.
  • Stemtech's Liabilities and Shareholders Equity (Quarter) stood at $5.7 million in 2021, then decreased by 25.4% to $4.3 million in 2022, then fell by 13.68% to $3.7 million in 2023, then rose by 2.69% to $3.8 million in 2024, then fell by 0.7% to $3.8 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $3.8 million for Q3 2025, versus $3.9 million for Q2 2025 and $3.8 million for Q1 2025.